<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03447002</url>
  </required_header>
  <id_info>
    <org_study_id>ErciyesU</org_study_id>
    <nct_id>NCT03447002</nct_id>
  </id_info>
  <brief_title>Urine Levels of Metanephrin and Normetanephrin in Patients With Frequent Ventricular Premature Complex</brief_title>
  <official_title>Urine Levels of Metanephrin and Normetanephrin in Patients With Frequent Ventricular Premature Complex</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TC Erciyes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TC Erciyes University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Enhanced automaticity process is the underlying mechanism for arrhythmias due to excess
      catecholamines. Catecholamines may increase in patients with PVC. Metabolites of
      catecholamines are metanephrine and normetanephrine. Our aim is to measure 24 hours urine
      levels of metanephrine and normetanephrine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Premature ventricular complex is a very frequent arrhythmia. Suggested mechanisms for PVCs
      are reentry, triggered activity, and enhanced automaticity. Enhanced automaticity process is
      the underlying mechanism for arrhythmias due to excess catecholamines. Catecholamines may
      increase in patients with PVC. Half-lives of catecholamines are very short and rather
      changeable. Therefore, 24 hours urine levels of catecholamines are the more sensitive than
      plasma levels. Metabolites of catecholamines are metanephrine and normetanephrine. Our aim is
      to measure 24 hours urine levels of metanephrine and normetanephrine.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 15, 2018</start_date>
  <completion_date type="Anticipated">January 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>metanephrine and normetanephrine levels</measure>
    <time_frame>about 10 months</time_frame>
    <description>metanephrine and normetanephrine levels asociated premature ventricular complex frequents</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Premature Ventricular Contraction</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>24 hours urine levels metanephrine and normetanephrine</intervention_name>
    <description>24 hours rhythm recording and 24 hours urine measurement</description>
    <other_name>rhythm recording</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with % 5 or higher frequents premature ventricular complex in 24 hours rhythm
        recording will be taken our study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PVC's rate is more than % 5 in 24 hours rhythm recording

        Exclusion Criteria:

          -  ischemic heart disease

          -  hyperthyroidism

          -  patients with low ejection fraction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Burak cesur, M.D</last_name>
    <phone>905455387438</phone>
    <phone_ext>903522076666</phone_ext>
    <email>drburax@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ramazan topsakal, M.D</last_name>
    <phone>905326433244</phone>
    <phone_ext>903522076666</phone_ext>
    <email>topsakal@erciyes.edu.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Erciyes university Yilmaz- mehmet öztaşkın heart hospital</name>
      <address>
        <city>Kayseri</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>burak cesur, m.d</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Im SI, Park KM, Park SJ, Kim JS, On YK. New electrocardiographic criteria for predicting successful ablation of premature ventricular contractions from the right coronary cusp. Int J Cardiol. 2016 Dec 1;224:199-205. doi: 10.1016/j.ijcard.2016.09.029. Epub 2016 Sep 16.</citation>
    <PMID>27657474</PMID>
  </reference>
  <reference>
    <citation>Bradfield JS, Homsi M, Shivkumar K, Miller JM. Coupling interval variability differentiates ventricular ectopic complexes arising in the aortic sinus of valsalva and great cardiac vein from other sources: mechanistic and arrhythmic risk implications. J Am Coll Cardiol. 2014 May 27;63(20):2151-2158. doi: 10.1016/j.jacc.2014.02.551. Epub 2014 Mar 19.</citation>
    <PMID>24657687</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2018</study_first_submitted>
  <study_first_submitted_qc>February 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2018</study_first_posted>
  <last_update_submitted>February 24, 2018</last_update_submitted>
  <last_update_submitted_qc>February 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>TC Erciyes University</investigator_affiliation>
    <investigator_full_name>Burak Cesur</investigator_full_name>
    <investigator_title>burak cesur</investigator_title>
  </responsible_party>
  <keyword>premature</keyword>
  <keyword>pvc</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Ventricular Premature Complexes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

